Physician profile
Chad Johnston
NPI 1538239520
$4,532.43
in general payments reported to CMS, 2019-2025
9 companies · $42.41 in 2025
The $42.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.27 · 2020: $144 · 2021: $1,551 · 2022: $2,015 · 2023: $550 · 2024: $168 · 2025: $42.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $3,837.47 | 2021-2024 | Lucemyra, Zimhi |
| Indivior INC. | $254.74 | 2019-2023 | Sublocade |
| Alkermes, INC. | $184.62 | 2022-2023 | Vivitrol |
| Janssen Biotech, INC. | $145.18 | 2024 | Tremfya |
| Orexo US, INC. | $45.47 | 2019-2022 | |
| Abbvie INC. | $23.09 | 2025 | |
| Novo Nordisk INC | $19.32 | 2025 | |
| Galderma Laboratories, L.P. | $11.49 | 2019 | |
| Mdd US Operations, LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.